No Detail Found!

The Influence of OPRM1 A118G polymorphism on the dosage of morphine in patients with advanced liver cancer

Author(s)
Hongzhen Cheng Department of Pharmacy, Changyi People's Hospital,Weifang City, Shandong Province,China
Xiaoyan Chu Department of Pharmacy, Changyi People's Hospital,Weifang City, Shandong Province,China
Shenghua Yi Outpatient Office, Changyi People's Hospital,Shandong Province,China
Abstract
This study was conducted ot investigate the in uence of ¼-opioid receptor ge(nOePRM1) A118G polymorphism on dosage of morphine in advanced liver cancer patients. Seventy patients with advanced liver cancer at Changyi People's Hospital, Shandong Province, China, were included from February 2019 to December 2020. The dosage of morphine in patients withOPRM1 A118G di erent genotypes was compared. Thirty patients (42.86%)were of AA genotype, 35 (50.00%) were AG genotype and 5 (7.14%) were GG genotype. There was a signi cant di erence in morphine dosage within the rst 24 hours in patients withAA, AG and GG genotypes (all p <0.001), and morphine dosage in patients with GG genotype was the highest. In conclusion, OPRM1 A118G genotype may a ect the dosage of morphine in advanced liver cancer patients. More dosages of morphine are needed for pain control in patients with G allele.
Publication Details
Page(s) 1375-1377
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 11, Year: 2021

Request the full text from PASTIC

Keywords
Morphine, Liver Cancer, Gene polymorphism, ¼-opioid receptor gene (OPRM1)
0

Citations

0

Downloads

99

Views